Editors' ChoiceImmunology HER2 reduces the STING Erin R. WilliamsScience Signaling, AAAS, Washington, DC 20005, USA See allHide authors and affiliations Science Signaling 06 Aug 2019:Vol. 12, Issue 593, eaay9834DOI: 10.1126/scisignal.aay9834 Erin R. Williams , AAAS, Washington, DC 20005, USAFind this author on Google Scholar Find this author on PubMed Search for this author on this site Article Info & Metrics eLetters Article Information vol. 12 no. 593 DOI: https://doi.org/10.1126/scisignal.aay9834 Published By: Science Signaling Print ISSN: 1945-0877 Online ISSN: 1937-9145 History: . Copyright & Usage: Copyright © 2019, American Association for the Advancement of Science Author Information Erin R. WilliamsScience Signaling, AAAS, Washington, DC 20005, USA Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: August 2019 to March 2021 AbstractFullPdf Aug 201919531273 Sep 2019162332 Oct 201961380 Nov 20195937 Dec 201941051 Jan 20202720 Feb 20204590 Mar 20203430 Apr 20202500 May 20200270 Jun 20202810 Jul 20202710 Aug 20202950 Sep 20201672 Oct 20204620 Nov 20202520 Dec 20204600 Jan 20213240 Feb 20210403 Mar 2021040 View Full Text
HER2 reduces the STING By Erin R. Williams Science Signaling06 Aug 2019 The receptor tyrosine kinase HER2 inhibits STING activation and limits the immune response to DNA virus infection and cancer.
HER2 reduces the STING By Erin R. Williams Science Signaling06 Aug 2019 The receptor tyrosine kinase HER2 inhibits STING activation and limits the immune response to DNA virus infection and cancer.